Literature DB >> 3595381

Esophageal chest pain. Value of high-dose provocative testing with edrophonium chloride in patients with normal esophageal manometries.

C A Lee, J C Reynolds, A Ouyang, L Baker, S Cohen.   

Abstract

The unequivocal diagnosis of esophageal chest pain requires the demonstration of simultaneous manometric changes and chest pain. Numerous provocative agents have been used to enhance the diagnostic value of esophageal manometry. Our aims were to: evaluate consecutively a large group of patients with proven noncardiac chest pain and normal baseline manometric studies, using edrophonium chloride, 10 mg, and determine the value of provocative testing in clinical practice. One hundred twenty patients with normal standard baseline esophageal manometries were studied using blinded testing with edrophonium chloride and followed clinically by questionnaire. A positive response of both chest pain and manometric changes was observed in 34%, a negative response in 49%, and an indeterminate response in 17% of patients. Baseline manometric features, including high-amplitude contractions, did not predict the response to edrophonium chloride. Following edrophonium chloride administration, the change in amplitude, duration, and number of repetitive contractions from baseline was significantly greater in positive responders. Edrophonium decreased the velocity of propagated contractions in positive responders (P less than 0.05), but not in nonresponders. Response to edrophonium chloride could not be predicted by patient age, sex, or clinical symptomatology. Seventy percent of patients in both groups had symptoms indistinguishable from ischemic heart disease. After making a specific diagnosis of esophageal chest pain, patients showed a marked clinical improvement, with a significant decrease in physical limitation, emergency room visits, hospital and CCU admissions, and in further cardiac testing. We conclude that provocative testing with edrophonium chloride will make it possible to definitively implicate the esophagus in over 30% of patients with normal baseline manometric findings and noncardiac chest pain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595381     DOI: 10.1007/bf01296132

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Symptomatic diffuse esophageal spasm. Manometric follow-up and response to cholinergic stimulation and cholinesterase inhibition.

Authors:  M Mellow
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

2.  Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm.

Authors:  A J DiMarino
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

3.  Esophageal manometrics in patients with angina-like chest pain.

Authors:  D L Brand; D Martin; C E Pope
Journal:  Am J Dig Dis       Date:  1977-04

4.  Oesophageal sensitivity to Mecholyl in symptomatic diffuse spasm.

Authors:  P Kramer; B Fleshler; E McNally; L D Harris
Journal:  Gut       Date:  1967-04       Impact factor: 23.059

5.  The effects of pentagastrin in achalasia and diffuse esophageal spasm.

Authors:  R C Orlando; E M Bozymski
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

6.  Diagnosis of oesophageal spasm by ergometrine provocation.

Authors:  H A Davies; M D Kaye; J Rhodes; A M Dart; A H Henderson
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

7.  Contraction abnormalities of the esophageal body in patients referred to manometry. A new approach to manometric classification.

Authors:  R E Clouse; A Staiano
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

8.  Ergonovine-induced esophageal spasm in patients with chest pain resembling angina pectoris.

Authors:  K L Koch; R C Curry; R L Feldman; C J Pepine; A Long; J R Mathias
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

9.  Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction.

Authors:  S B Benjamin; J E Richter; C M Cordova; T E Knuff; D O Castell
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

10.  Provocation of esophageal pain by ergonovine or edrophonium.

Authors:  R L London; A Ouyang; W J Snape; S Goldberg; J W Hirshfeld; S Cohen
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  20 in total

1.  Acid perfusion and edrophonium provocation tests in patients with chest pain of undetermined etiology.

Authors:  T Rokkas; A Anggiansah; M McCullagh; W J Owen
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Diagnosis of chest pain of esophageal origin. A guideline of the Patient Care Committee of the American Gastroenterological Association.

Authors:  T H Browning
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

Review 3.  Circadian rhythm as a therapeutic target.

Authors:  Wei Ruan; Xiaoyi Yuan; Holger K Eltzschig
Journal:  Nat Rev Drug Discov       Date:  2021-02-15       Impact factor: 84.694

4.  Prospective evaluation of high-dose bethanechol in investigation of esophageal chest pain.

Authors:  W K Deschner; K A Maher; E L Cattau; S B Benjamin
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

5.  Esophageal motility and psychiatric factors in functional dyspepsia patients with or without pain.

Authors:  M Handa; K Mine; H Yamamoto; S Tsutsui; H Hayashi; N Kinukawa; C Kubo
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

6.  Manometric investigation of the entire esophagus in healthy subjects and patients with high-amplitude peristaltic contractions.

Authors:  G Bassotti; G Bacci; D Biagini; P David; G Alunni; M A Pelli; A Morelli
Journal:  Dysphagia       Date:  1988       Impact factor: 3.438

7.  Edrophonium testing for esophageal pain. Concurrence and discord.

Authors:  D O Castell; J E Richter
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

8.  Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter.

Authors:  L S Miller; H P Parkman; T D Schiano; M J Cassidy; R B Ter; M A Dabezies; S Cohen; R S Fisher
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

9.  Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome.

Authors:  L A Nair; J C Reynolds; H P Parkman; A Ouyang; B L Strom; E F Rosato; S Cohen
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

10.  Comparison of intravenous edrophonium and oesophageal acid perfusion during oesophageal manometry in patients with non-cardiac chest pain.

Authors:  J S De Caestecker; A Pryde; R C Heading
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.